Literature DB >> 27408210

Toxic Epidermal Necrolysis Managed with Immunoglobulin: Reply.

G D Choudhury1, Vikas Agarwal2.   

Abstract

Year:  2011        PMID： 27408210      PMCID： PMC4921517          DOI： 10.1016/S0377-1237(09)80082-8

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  5 in total

Review 1.  Toxic epidermal necrolysis and intravenous immunoglobulin: a review.

Authors:  Jennifer Trent; Monica Halem; Lars E French; Francisco Kerdel
Journal:  Semin Cutan Med Surg       Date:  2006-06

Review 2.  Toxic epidermal necrolysis.

Authors:  Frederick A Pereira; Adarsh Vijay Mudgil; David M Rosmarin
Journal:  J Am Acad Dermatol       Date:  2007-02       Impact factor: 11.527

3.  Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative beta-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability.

Authors:  Philippe Paquet; Eric Jacob; Pierre Damas; Gérald E Piérard
Journal:  Crit Care Med       Date:  2002-11       Impact factor: 7.598

4.  Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins.

Authors:  Antonino Romano; Rosa-Maria Guéant-Rodriguez; Marinella Viola; Rosa Pettinato; Jean-Louis Guéant
Journal:  Ann Intern Med       Date:  2004-07-06       Impact factor: 25.391

5.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

Authors:  I Viard; P Wehrli; R Bullani; P Schneider; N Holler; D Salomon; T Hunziker; J H Saurat; J Tschopp; L E French
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.